Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

North American phase III trial initiated for Alzhemed

June 25, 2004

Recent pregabalin study results presented at epilepsy congress

June 23, 2004

Sativex improves spasticity in MS patients in phase III trial

June 23, 2004

5-HT reuptake inhibitors and 5-HT receptor agonists developed at Merck KGaA

June 23, 2004

Novel GABA-A receptor ligands in early development at Neurogen

June 23, 2004

ExonHit develops improved formulation of Ikomio

June 23, 2004

Guilford licenses U.S. rights to GPI-1485 to Symphony Neuro Development Company

June 22, 2004

Potent in vivo antinociceptive effects of orally active agent by Mochida

June 22, 2004

Guilford patent covers new DPPIV inhibitors and their therapeutic use

June 21, 2004

Results from confirmatory phase II study of Aquavan

June 21, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026